ClassID:

20950

A61K38/1833 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II

Recent Application in this class:
#1
20260069640
2026-03-12

MICRONIZED COMPOSITIONS FOR WOUND HEALING PREPARED FROM INTACT HUMAN AMNION-CHORION TISSUE HAVING AN INTACT INTERMEDIATE SPONGY LAYER POSITIONED THERE BETWEEN

#2
20260015628
2026-01-15

AAV VECTOR OPTIMIZED FOR INTRATHECAL ADMINISTRATION INTO WHICH HEPATOCYTE GROWTH FACTOR GENE IS INTRODUCED

#3
20250381247
2025-12-18

SPINAL CORD INJURY THERAPEUTIC TARGETING FROM ACUTE PHASE TO SUBACUTE PHASE

#4
20250302873
2025-10-02

ALLOGENEIC HUMAN PLASMA AND PLATELET DERIVED PRODUCTS AND USES THEREOF

#5
20250222035
2025-07-10

PROCESSES FOR MAKING AND USING A MESENCHYME STEM CELL SECRETOME FOR LIMBAL STEM CELL DEFICIENCY (LSCD) TREATMENT

#6
20250205289
2025-06-26

MICRONIZED COMPOSITIONS FOR WOUND HEALING PREPARED FROM INTACT HUMAN AMNION-CHORION TISSUE HAVING AN INTACT INTERMEDIATE SPONGY LAYER POSITIONED THERE BETWEEN

#7
20250197477
2025-06-19

PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITION

#8
20250195423
2025-06-19

GROWTH FACTOR LOADED NANOFIBERS AND METHODS OF USE THEREOF

#9
20250186506
2025-06-12

HUMAN UMBILICAL CORD COMPOSITION FOR TREATMENT OF PEYRONIE'S DISEASE

#10
20250177486
2025-06-05

THERAPEUTIC AGENT FOR SPINAL CORD INJURY

#11
20250177455
2025-06-05

NOVEL THERAPEUTIC COMPRISING A SECRETOME FROM MESENCHYMAL STEM CELLS OF UMBILICORD TISSUE OR WHARTON'S JELLY

#12
20250152636
2025-05-15

CARDIAC STEM CELLS FOR CARDIAC REPAIR

#13
20250144150
2025-05-08

PREPARATION METHOD OF PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC STROKE

#14
20250135008
2025-05-01

ADHESIVE CELL TISSUE GELS

#15
20250115721
2025-04-10

HYDROGEL COMPOSITION, METHOD FOR PRODUCING THE SAME, AND USE THEREOF FOR STEM CELL MIMETIC PEPTIDE SUPPLEMENTATION

#16
20250108006
2025-04-03

BIOACTIVE GRANULAR HYDROGEL SCAFFOLDS AND USE THEREOF

#17
20250090634
2025-03-20

LYMPHANGIOGENESIS-PROMOTING AGENTS

#18
20250064776
2025-02-27

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS

#19
20250032553
2025-01-30

CARDIAC STEM CELLS FOR CARDIAC REPAIR

#20
20240428915
2024-12-26

Methods for Treating and Diagnosing Risk of Renal Allograft Fibrosis and Rejection

#21
20240415932
2024-12-19

Systems and Methods for Angiogenic Treatment in Wound Healing

#22
20240408148
2024-12-12

HUMAN UMBILICAL COMPOSITIONS AND METHODS FOR DERMAL APPLICATION

#23
20240374694
2024-11-14

METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SPINAL CORD INJURY

#24
20240325455
2024-10-03

CARDIAC STEM CELLS FOR CARDIAC REPAIR

#25
20240269324
2024-08-15

Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of ANG, ANGPT1, VEGFA, FGF1, HIF1a, HGF, SDF1, KLK4, PDGFC, PROK1, and PROK2 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-ANG, or Escherichia coli strain SCS110-AF/VTvaf17-ANGPT1, or Escherichia coli strain SCS110-AF/VTvaf17-VEGFA, or Escherichia coli strain SCS110-AF/VTvaf17-FGF

#26
20240245731
2024-07-25

Micronized compositions for wound healing prepared from intact human amnion-chorion tissue having an intact intermediate spongy layer positioned there between

#27
20240173381
2024-05-30

HB-EGF GENE THERAPY FOR DIABETES

#28
20240123032
2024-04-18

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORNEAL HAZE AND SCARRING

#29
20240033298
2024-02-01

Cardiac stem cells for cardiac repair

#30
20240033297
2024-02-01

PROCESSES FOR MAKING AND USING A MESENCHYMAL STEM CELL DERIVED SECRETOME

#31
20240012011
2024-01-11

METHODS AND ASSAYS FOR SECRETOME ACTIVITY ANALYSIS

#32
20240000851
2024-01-04

Cardiac stem cells for cardiac repair

#33
20230414718
2023-12-28

LOW-DOSE HEPATOCYTE GROWTH FACTOR GENE THERAPY FOR DIABETES

#34
20230391847
2023-12-07

Methods for treating an ocular condition with cellular fibronectin compositions

#35
20230390211
2023-12-07

COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT

#36
20230330183
2023-10-19

STEM CELL CONDITIONED MEDIA FOR CLINICAL AND COSMETIC APPLICATIONS

#37
20230321155
2023-10-12

Use of Cell-Free Fat Extract for Treating Osteoporosis

#38
20230293597
2023-09-21

Cardiac stem cells for cardiac repair

#39
20230285468
2023-09-14

EFFECTS OF CELL-FREE FAT LIQUID EXTRACT ON MACROPHAGE POLARIZATION MODULATION AND DISEASE TREATMENT

#40
20230158126
2023-05-25

RNA FOR TREATMENT OR PROPHYLAXIS OF A LIVER DISEASE

#41
20230046238
2023-02-16

COMPOSITION AND USE THEREOF

#42
20230040943
2023-02-09

MEDICAMENT COMPRISING A COMBINATION OF AMNIOTIC MEMBRANE AND UMBILICAL CORD BLOOD SERUM FOR WOUND HEALING

#43
20230022990
2023-01-26

COMPOSITIONS OF GROWTH FACTOR FOR THE TREATMENT OF EYE DISEASE

#44
20230002476
2023-01-05

Cellular fibronectin compositions

#45
20230000954
2023-01-05

Processes for making a cellular fibronectin composition

#46
20220401518
2022-12-22

MESENCHYMAL STEM CELL EXPRESSING HEPATOCYTE GROWTH FACTOR, AND USE THEREOF

#47
20220370508
2022-11-24

HUMAN UMBILICAL CORD COMPOSITIONS AND METHODS FOR INTRA-ARTICULAR THERAPY

#48
20220362338
2022-11-17

TREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY

#49
20220296679
2022-09-22

TREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY

#50
20220249612
2022-08-11

COMPOSITIONS FOR TREATMENT OF AZOOSPERMIA, METHODS FOR PREPARING THE SAME AND APPLICATIONS THEREOF

#51
20220184181
2022-06-16

METHODS OF OCULAR TREATMENT USING AN ENGINEERED DIMERIC FRAGMENT OF HEPATOCYTE GROWTH FACTOR

#52
20220184028
2022-06-16

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS

#53
20220168472
2022-06-02

ENZYME-DEGRADABLE HYDROGEL FOR DELIVERY OF A PAYLOAD

#54
20220118050
2022-04-21

POLYETHYLENE GLYCOL-MODIFIED FORM OF HEPATOCYTE GROWTH FACTOR OR ACTIVE FRAGMENT THEREOF

#55
20220088141
2022-03-24

LYMPHANGIOGENESIS-PROMOTING AGENTS

#56
20220031761
2022-02-03

COMPOSITIONS FOR PROMOTING SKIN REGENERATION, SKIN REJUVENATION, AND WOUND HEALING AND METHODS FOR PREPARATION AND USE THEREOF

#57
20220023385
2022-01-27

ENGINEERED FIBROBLAST GROWTH FACTOR VARIANTS COMBINED WITH ENGINEERED HEPATOCYTE GROWTH FACTOR VARIANTS FOR TREATMENT

#58
20210299219
2021-09-30

Compositions and methods for prevention and treatment of corneal haze and scarring

#59
20210283183
2021-09-16

COMPOSITION FOR PREVENTING OR TREATING PULMONARY FIBROSIS CONTAINING EXOSOME ISOLATED FROM ADIPOSE-DERIVED STEM CELL AS ACTIVE INGREDIENT

#60
20210187038
2021-06-24

Cardiac stem cells for cardiac repair

#61
20210187034
2021-06-24

Processes for making and using a mesenchymal stem cell derived secretome

#62
20210113668
2021-04-22

Composition for increasing the expression of a growth factor gene, comprising coreshell structured microparticles as active ingredient

#63
20210052656
2021-02-25

Processes for making and using a mesenchymal stem cell derived secretome

#64
20210046161
2021-02-18

SKIN OINTMENT FOR TREATING LABIA MINORA SKIN

#65
20210041455
2021-02-11

Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

#66
20200399657
2020-12-24

Adeno-associated virus vector

#67
20200354420
2020-11-12

GENE THERAPY FOR DIABETIC NEUROPATHY USING AN HGF ISOFORM

#68
20200325493
2020-10-15

Adeno-associated virus virion for gene transfer to nervous system cells

#69
20200325452
2020-10-15

Processes for making and using a mesenchymal stem cell derived secretome

#70
20200325249
2020-10-15

Visible light-curable water-soluble chitosan derivative, chitosan hydrogel, and preparation method therefor

#71
20200237873
2020-07-30

Systems and methods for angiogenic treatment in wound healing

#72
20200171206
2020-06-04

Compositions and methods for improving cardiac function

#73
20200171109
2020-06-04

Method for inducing production of vascular endothelial growth factor

#74
20200171092
2020-06-04

THERAPEUTIC AGENT FOR DILATED CARDIOMYOPATHY

#75
20200121758
2020-04-23

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORNEAL HAZE AND SCARRING

#76
20200121596
2020-04-23

Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction

#77
20200054715
2020-02-20

Treatment of collagen defects using protein solutions

#78
20200011855
2020-01-09

COMPOSITION FOR PREVENTING OR TREATING LIVER FIBROSIS OR CIRRHOSIS, COMPRISING EXPRESSION OR ACTIVITY ENHANCER OF TIF1y AS ACTIVE INGREDIENT

#79
20190388476
2019-12-26

COMPOSITIONS AND METHODS FOR TREATING AND REPAIRING TENDONS

#80
20190381138
2019-12-19

TREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY

#81
20190374617
2019-12-12

Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides

#82
20190343933
2019-11-14

RNA for treatment or prophylaxis of a liver disease

#83
20190321444
2019-10-24

LYMPHANGIOGENESIS-PROMOTING AGENTS

#84
20190241632
2019-08-08

Gene therapy for diabetic neuropathy using an HGF isoform

#85
20190225661
2019-07-25

Compositions and methods for vascular protection against reperfusion injury after myocardial ischemia

#86
20190224257
2019-07-25

Drug composition for angiogenesis therapy

#87
20190209650
2019-07-11

METHOD TO IMPROVE THE EFFECTIVENESS OF ANTI-CANCER THERAPIES BY EXPOSING CANCER CELLS TO AN INFLAMMATORY STIMULUS PRIOR TO TREATMENT

#88
20190204340
2019-07-04

USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME

#89
20190201229
2019-07-04

Noxipoints stimulating devices using light, mechanical force, or heat as a source of stimulation

#90
20190192577
2019-06-27

Postpartum cells derived from placental tissue, and methods of making and using the same

#91
20190153383
2019-05-23

Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell

#92
20190117782
2019-04-25

CELLULARIZED HYDROGELS AND METHODS OF USING THE SAME

#93
20190117732
2019-04-25

HGF preparation suitable for treatment of neurological disorders

#94
20190060465
2019-02-28

Adhesive cell tissue gels

#95
20190054144
2019-02-21

PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC STROKE AND METHOD THEREOF

#96
20190038717
2019-02-07

MESENCHYMAL STEM CELL EXPRESSING HEPATOCYTE GROWTH FACTOR, AND USE THEREOF

#97
20180338999
2018-11-29

Soft tissue repair and regeneration using postpartum-derived cells and cell products

#98
20180325946
2018-11-15

Composition for treatment of damaged part

#99
20180296605
2018-10-18

Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis

#100
20180256685
2018-09-13

Compositions and methods for prevention and treatment of corneal haze and scarring

#101
20180228847
2018-08-16

Compositions and methods for cardiac tissue repair

#102
20180222955
2018-08-09

GENE THERAPY FOR DIABETIC NEUROPATHY USING AN HGF ISOFORM

#103
20180214575
2018-08-02

Composition For Targeted Delivery Of Nucleic Acid-Based Therapeutics

#104
20180125895
2018-05-10

Cardiac stem cells for cardiac repair

#105
20180055674
2018-03-01

Wearable noxipoints stimulating devices

#106
20180008723
2018-01-11

MULTIMERIC COMPOUNDS OF A KRINGLE DOMAIN FROM THE HEPATOCYTE GROWTH FACTOR / SCATTER FACTOR (HGF/SF)

#107
20170369545
2017-12-28

MET receptor agonist proteins

#108
20170355960
2017-12-14

Immortalized stem cell, compositions, preparations and uses thereof

#109
20170333527
2017-11-23

HGF preparation suitable for treatment of neurological disorders

#110
20170326183
2017-11-16

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#111
20170281729
2017-10-05

Method for treating peripheral vascular disease using hepatocyte growth factor and stromal cell derived factor 1A

#112
20170273816
2017-09-28

Methods of and devices for chemical and threshold-gated electrical neuro-immuno-stimulation

#113
20170239299
2017-08-24

Postpartum cells derived from placental tissue, and methods of making and using the same

#114
20170224815
2017-08-10

Method of Preventing and Treating Retinal Microvasculature Inflammation Using C-Met Signaling Pathway Inhibition

#115
20170224773
2017-08-10

Pharmaceutical composition for treating and/or preventing esophageal stenosis

#116
20170216362
2017-08-03

Cell sheet composition for inhibiting progression of renal disorder, method of producing the same, and method of inhibiting progression of renal disorder using the same

#117
20170189487
2017-07-06

Lyophilized formulation of HGF

#118
20170182100
2017-06-29

Conditioned medium of liver progenitor cells

#119
20170166864
2017-06-15

Postpartum cells derived from placental tissue, and methods of making and using the same

#120
20170166863
2017-06-15

Postpartum cells derived from placental tissue, and methods of making and using the same

#121
20170157018
2017-06-08

Method of preparing a growth factor concentrate

#122
20170143770
2017-05-25

Soft tissue repair and regeneration using postpartum-derived cells and cell products

#123
20170112902
2017-04-27

Methods of treating amyotrophic lateral sclerosis by HGF

#124
20170087213
2017-03-30

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors

#125
20170073636
2017-03-16

Generating hepatocytes

#126
20170043054
2017-02-16

Preparations containing hepatocyte growth factor and hyaluronic acid, and methods of making and using same

#127
20160348076
2016-12-01

Usage of odontogenic stem cells and genetically modified odontogenic stem cells

#128
20160324924
2016-11-10

COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX

#129
20160324898
2016-11-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#130
20160271219
2016-09-22

LYMPHANGIOGENESIS-PROMOTING AGENTS

#131
20160250291
2016-09-01

Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor

#132
20160250290
2016-09-01

GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE

#133
20160166645
2016-06-16

Treatment of collagen defects using protein solutions

#134
20160120897
2016-05-05

Dextran sulfate for use in mobilization of cells

#135
20160106858
2016-04-21

Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides

#136
20160074479
2016-03-17

METHODS OF TREATING SPINAL DISORDERS USING AUTOLOGOUS PROTEIN SOLUTIONS

#137
20160067283
2016-03-10

Compositions and methods for cardiac tissue repair

#138
20160038569
2016-02-11

Particles containing a growth factor, and uses thereof

#139
20160033529
2016-02-04

Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

#140
20160000830
2016-01-07

Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis

#141
20150374757
2015-12-31

Compositions and methods for treating and repairing tendons

#142
20150283073
2015-10-08

Cancer cell trap

#143
20150238531
2015-08-27

Urine stem cells for skeletal muscle generation and uses thereof

#144
20150175962
2015-06-25

Generating hepatocytes

#145
20150165203
2015-06-18

Methods of and devices for chemical and threshold-gated electrical neuro-immuno-stimulation that triggers the stem cell growth to restore bodily functions

#146
20150164994
2015-06-18

Systems and methods for angiogenic treatment in wound healing

#147
20150071877
2015-03-12

Bioactive compositions and methods for their preparation and use

#148
20150010506
2015-01-08

THERAPEUTIC PLACENTAL COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE

#149
20150010497
2015-01-08

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors

#150
20140296142
2014-10-02

Gene therapy for diabetic neuropathy using an HGF isoform

#151
20140287996
2014-09-25

Neuroprotection by hepatic cells and hepatocyte secretory factors

#152
20140274899
2014-09-18

Preparations containing hepatocyte growth factor and hyaluronic acid and methods of making and using same

#153
20140274893
2014-09-18

Acellular compositions for treating inflammatory disorders

#154
20140234341
2014-08-21

Acute hepatic insufficiency depressant and method for evaluating drug efficacy thereof

#155
20140219953
2014-08-07

ADHESIVE CELL TISSUE GELS

#156
20140199377
2014-07-17

MULTIPLE GROWTH FACTOR COMPOSITIONS, METHODS OF FABRICATION, AND METHODS OF TREATMENT

#157
20140088502
2014-03-27

Multi-Needle Injection Apparatus and System for Delivering Pharmacological Agents to Biological Tissue

#158
20130337076
2013-12-19

Particles containing a growth factor, and uses thereof

#159
20130315997
2013-11-28

Parenteral composition comprising microspheres with a diameter between 10 and 20 microns

#160
20130309304
2013-11-21

COMPOUNDS AND METHODS

#161
20130224836
2013-08-29

Adeno-associated virus vector for gene transfer to nervous system cells

#162
20130217624
2013-08-22

Composition and method for the inhibition of postoperative adhesions severity

#163
20130216626
2013-08-22

Platelet-rich plasma compositions

#164
20130172418
2013-07-04

Pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder

#165
20130149280
2013-06-13

Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation

#166
20130149241
2013-06-13

Peptide radiotracer compositions

#167
20130130982
2013-05-23

Neuroprotection by hepatic cells and hepatocyte secretory factors

#168
20130095060
2013-04-18

PHARMACEUTICAL COMPOSITION FOR PROMOTING ARTERIOGENESIS, AND PREPARATION METHOD AND APPLICATIONS FOR THE SAME

#169
20130064833
2013-03-14

Monitoring and modulating HGF/HGFR activity

#170
20130023475
2013-01-24

C-Met receptor regulation by angiotensin IV (AT4) receptor ligands

#171
20130022585
2013-01-24

Regeneration and repair of neural tissue using postpartum-derived cells

#172
20130022584
2013-01-24

Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof

#173
20130011464
2013-01-10

DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS

#174
20120328557
2012-12-27

ADHESIVE CELL TISSUE GELS

#175
20120282324
2012-11-08

Methods for promoting the revascularization and reenervation of CNS lesions

#176
20120237473
2012-09-20

Compositions And Methods For Cell Based Retinal Therapies

#177
20120195939
2012-08-02

PARENTERAL COMPOSITION COMPRISING MICROSPHERES WITH A DIAMETER BETWEEN 10 AND 20 MICRONS

#178
20120189691
2012-07-26

Drug carrier and drug carrier kit for inhibiting fibrosis

#179
20120157381
2012-06-21

Compositions and methods for cardiac tissue repair

#180
20120156170
2012-06-21

DRUG COMPOSITION FOR ANGIOGENESIS THERAPY

#181
20120149642
2012-06-14

Fibrosis inhibitor for implanted organ

#182
20120076852
2012-03-29

Drug carrier and drug carrier kit for inhibiting fibrosis

#183
20120071405
2012-03-22

COMPOSITION OF INHIBITING PATHOLOGICAL ANGIOGENESIS

#184
20120021040
2012-01-26

Therapeutic agent for spinal cord injuries

#185
20110312887
2011-12-22

Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue

#186
20110230407
2011-09-22

HEPATOCYTE GROWTH FACTOR PATHWAY ACTIVATORS IN DEMYELINATING DISEASES AND CENTRAL NERVOUS SYSTEM TRAUMA

#187
20110165095
2011-07-07

Composition and method for the inhibition of postoperative adhesions severity

#188
20110160132
2011-06-30

LYMPHANGIOGENESIS-PROMOTING AGENTS

#189
20110142773
2011-06-16

Composition and periodical delivery system for cellular rejuvenation

#190
20110129439
2011-06-02

Conditioned medium of liver progenitor cells

#191
20110091550
2011-04-21

Methods for promoting the revascularization and reenervation of CNS lesions

#192
20110045061
2011-02-24

GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE

#193
20110038921
2011-02-17

METHODS AND COMPOSITIONS FOR TEMPORAL RELEASE OF AGENTS FROM A BIODEGRADABLE SCAFFOLD

#194
20100322998
2010-12-23

SKIN ULCER PREVENTIVE CURATIVE AGENT CONTAINING HUMAN RECOMBINANT HGF

#195
20100260843
2010-10-14

Regeneration and repair of neural tissue using postpartum-derived cells

#196
20100240735
2010-09-23

Compositions and methods for angiogenic therapy utilizing genes encoding ets-1

#197
20100227821
2010-09-09

MONITORING AND MODULATING HGF/HGFR ACTIVITY

#198
20100210013
2010-08-19

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#199
20100183560
2010-07-22

Angiogenesis-modulating compositions and uses

#200
20100168003
2010-07-01

Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof

#201
20100160223
2010-06-24

Synergetic Effects of HGF and Antibacterial Treatment

#202
20100137217
2010-06-03

Fibrosis inhibitor for implanted organ

#203
20100111908
2010-05-06

Induction of Renal Cells for Treatment of Kidney Disease

#204
20100081617
2010-04-01

THERAPEUTIC AGENT FOR SPINAL CORD INJURIES

#205
20100068190
2010-03-18

MESOANGIOBLAST-LIKE CELL AS WELL AS METHODS AND USES RELATING THERETO

#206
20090304650
2009-12-10

Repair of the Bone Marrow Vasculature

#207
20090233863
2009-09-17

HGF preparation

#208
20090221683
2009-09-03

Combination of CXCR4 Antagonist and Morphogen to Increase Angiogenesis

#209
20090209473
2009-08-20

Componds and methods for pormoting angiogenesis

#210
20090202606
2009-08-13

Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor

#211
20090169473
2009-07-02

DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR DISEASE ASSOCIATED WITH HEPATOCYTE GROWTH FACTOR RECEPTOR

#212
20090157046
2009-06-18

Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof

#213
20090143296
2009-06-04

Methods and compositions for the repair and/or regeneration of damaged myocardium

#214
20090082263
2009-03-26

DRUG AND METHOD FOR IMPROVING BRAIN FUNCTION

#215
20090076481
2009-03-19

Therapeutic angiogenesis for treatment of the spine

#216
20090068179
2009-03-12

Methods for Inhibiting Carcinogenesis and/or Metastasis in an Individual with Endogenous C-Met Ligands and Inhibitors

#217
20090047242
2009-02-19

CONDITIONED BLOOD COMPOSITION AND METHOD FOR ITS PRODUCTION

#218
20090028820
2009-01-29

Antiviral Agent

#219
20090023658
2009-01-22

Neovascularization Inhibitors Derived From HGF and Methods Involving the Same

#220
20090022802
2009-01-22

CARDIOMYOPATHY THERAPEUTIC AGENT

#221
20090012498
2009-01-08

Gene therapy for treatment of heart failure

#222
20090004260
2009-01-01

MEDICAMENT COMPRISING HGF GENE

#223
20080318863
2008-12-25

ISCHEMIA THERAPEUTIC AGENT

#224
20080317816
2008-12-25

Porous objects having immobilized encapsulated biomolecules

#225
20080293634
2008-11-27

C-Met receptor regulation by angiotensin IV (AT) receptor ligands

#226
20080274960
2008-11-06

Fibrosis inhibitor for implanted organ

#227
20080268030
2008-10-30

Gene therapy for diabetic ischemic disease

#228
20080260703
2008-10-23

Treatment of Insulin Resistance and Diabetes

#229
20080254109
2008-10-16

LOCALIZED MYOCARDIAL INJECTION METHOD FOR TREATING ISCHEMIC MYOCARDIUM

#230
20080233088
2008-09-25

PREPARATIVE REGIMEN FOR ENGRAFTMENT, GROWTH AND DIFFERENTIATION OF NON-HEMATOPOEITIC CELLS IN VIVO AFTER TRANSPLANTATION

#231
20080213348
2008-09-04

Agents for gene therapy of cerebrovascular disorders

#232
20080200375
2008-08-21

Angiogenesis using hepatocyte growth factor

#233
20080194473
2008-08-14

Hydrocephalus treatment

#234
20080193512
2008-08-14

Drug carrier and drug carrier kit for inhibiting fibrosis

#235
20080183134
2008-07-31

METHOD FOR FOSTERING BONE FORMATION AND PRESERVATION

#236
20080181880
2008-07-31

Method for fostering bone formation and preservation

#237
20080057051
2008-03-06

Method for fostering bone formation and preservation

#238
20080051343
2008-02-28

METHOD FOR FOSTERING BONE FORMATION AND PRESERVATION

#239
20080039380
2008-02-14

Agent for Prophylactic and/or Therapeutic Treatment of Retinopathy

#240
20080038234
2008-02-14

Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair

#241
20080031970
2008-02-07

Method of Promoting Natural Bypass

#242
20080025962
2008-01-31

Remedy for Alzheimer's Disease

#243
20080008701
2008-01-10

C-Met receptor regulation by angiotensin IV (AT) receptor ligands

#244
20070264321
2007-11-15

Method of treating skin ulcers with vectors encoding hepatocyte growth factor

#245
20070213261
2007-09-13

Asthma preparation

#246
20070197433
2007-08-23

Differentiation- or regeneration-inducing agent for alveoli

#247
20070172464
2007-07-26

Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same

#248
20070142279
2007-06-21

Agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor

#249
20070066935
2007-03-22

Needleless syringe having medical agent accomodated therein

#250
20070036767
2007-02-15

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#251
20070021335
2007-01-25

Agent for improving mental disorders

#252
20070014771
2007-01-18

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#253
20070010443
2007-01-11

Monitoring and modulating HGF/HGFR activity

#254
20070010436
2007-01-11

Remedy for cardiomyopathy

#255
20070009494
2007-01-11

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#256
20060264380
2006-11-23

Compounds and Methods for Promoting Angiogenesis

#257
20060251615
2006-11-09

Therapeutic agent for preventing and/or treating sepsis

#258
20060234911
2006-10-19

Method of reversing epithelial mesenchymal transition

#259
20060234376
2006-10-19

Repair and regeneration of ocular tissue using postpartum-derived cells

#260
20060233755
2006-10-19

Drug for auditory dysfunction

#261
20060229245
2006-10-12

Lyophilized HGF preparations

#262
20060228344
2006-10-12

Cell-containing preparations

#263
20060211612
2006-09-21

Angiogenesis using hepatocyte growth factor

#264
20060199762
2006-09-07

Skin ulcer preventive curative agent containing human recombinant hgf

#265
20060194729
2006-08-31

Method of promoting natural bypass

#266
20060193827
2006-08-31

Methods using TCF -II

#267
20060188983
2006-08-24

Postpartum-derived cells for use in treatment of disease of the heart and circulatory system

#268
20060183680
2006-08-17

Remedy for ischemia

#269
20060172922
2006-08-03

Methods for combating ischemic injury to epithelial organ

#270
20060154367
2006-07-13

Cartilage and bone repair and regeneration using postpartum-derived cells

#271
20060154366
2006-07-13

Method of differentiating umbilical cord tissue into a chondrogenic phenotype

#272
20060153818
2006-07-13

Cartilage and bone repair and regeneration using postpartum-derived cells

#273
20060153817
2006-07-13

Cartilage and bone repair and regeneration using postpartum-derived cells

#274
20060153816
2006-07-13

Soft tissue repair and regeneration using postpartum-derived cells and cell products

#275
20060134079
2006-06-22

Implantable medical devices comprising isolated extracellular matrix

#276
20060094656
2006-05-04

Method for fostering bone formation and preservation

#277
20060074036
2006-04-06

Agents for gene therapy of cerebrovascular disorders

#278
20060030517
2006-02-09

Anti-cancer agent

#279
20060002894
2006-01-05

Method for introducing a biological molecule using a viral envelope and heparin and system therefore

#280
20050256047
2005-11-17

Method for fostering bone formation and preservation

#281
20050250686
2005-11-10

Angiogenesis using hepatocyte growth factor

#282
20050238702
2005-10-27

Medical composition containing photocrosslinkable chitosan derivative

#283
20050238666
2005-10-27

Methods of enhancing stem cell engraftment

#284
20050058631
2005-03-17

Postpartum cells derived from placental tissue, and methods of making and using the same

#285
20050058630
2005-03-17

Postpartum-derived cells for use in treatment of disease of the heart and circulatory system

#286
20050058629
2005-03-17

Soft tissue repair and regeneration using postpartum-derived cells

#287
20050054098
2005-03-10

Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same

#288
20050037491
2005-02-17

Treatment of retinitis pigmentosa with human umbilical cord cells

#289
20050037092
2005-02-17

Vascularization therapy by highly concentrated carbonated warm water bath

#290
20050032209
2005-02-10

Regeneration and repair of neural tissue using postpartum-derived cells

#291
20050026830
2005-02-03

Compositions and methods for treating fibrosis

#292
20050019865
2005-01-27

Cartilage and bone repair and regeneration using postpartum-derived cells

#293
20050004029
2005-01-06

Methods and compositions for treating vascular leak using hepatocyte growth factor

#294
16785470
2020-09-01

Processes for making and using a mesenchymal stem cell derived secretome